Home
About
Services
Partners
Client Portfolio
News
Contact
Exclusive: Pershing Square’s Ackman eyes $1 billion-plus ‘blank-check’ company – sources
June 11, 2020
Oil prices set for worst daily drop since April on inventories, bearish Fed
June 11, 2020
0
Japan’s Takeda to sell some Asia-focused drugs to Celltrion for $278 million
Published by
Muller&Green
at
June 11, 2020
Categories
RSS
Tags
Takeda Pharmaceutical Co Ltd has agreed to sell a portfolio of over-the-counter and prescription drugs marketed in the Asia Pacific region to South Korea’s Celltrion Inc for $278 million, it said on Thursday
Powered by
WPeMatico
Muller&Green
Related posts
June 18, 2020
Chanel warns virus impact will linger on luxury sector
Read more
June 18, 2020
IMF says deeper-than-expected contraction in U.S. economy likely in second quarter
Read more
June 18, 2020
Prudential sells Jackson equity stake to Apollo-backed Athene for $500 million
Read more